TRAIL Deficiency Contributes to Diabetic Nephropathy in Fat-Fed ApoE-/- Mice

Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand

(2013) Nor Saadah M. Azahri et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

The osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the kidney

(2013) Riccardo Candido   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Cystatin C: An Emerging Biomarker in Cardiovascular Disease

(2013) Christos Angelidis et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Mycophenolate Mofetil and Valsartan Inhibit Podocyte Apoptosis in Streptozotocin-Induced Diabetic Rats

(2013) Wei Lv et al.   PHARMACOLOGY

TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL

(2013) Belinda A. Di Bartolo et al.   PLoS One

TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4+CD25+ Treg apoptosis

(2012) Zhijuan Diao et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate

(2012) Qing Xie et al.   Cardiovascular Diabetology

TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation

(2012) S Jouan-Lanhouet et al.   CELL DEATH AND DIFFERENTIATION

TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice

(2011) B. A. Di Bartolo et al.   DIABETOLOGIA

Novel transcript variants of TRAIL show different activities in activation of NF-κB and apoptosis

(2011) Pingzhang Wang et al.   LIFE SCIENCES

Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy

(2011) Yu-Hung Chang et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation

(2011) Anders Grubb et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Vascular Calcification

(2011) Maud Chasseraud et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Is a Marker of Kidney Function and Inflammation in Heart and Kidney Transplant Recipients

(2011) J. Malyszko et al.   TRANSPLANTATION PROCEEDINGS

TRAIL Promotes VSMC Proliferation and Neointima Formation in a FGF-2–, Sp1 Phosphorylation–, and NFκB-Dependent Manner

(2010) Jeffrey Chan et al.   CIRCULATION RESEARCH

Association between cystatin C and inflammation in patients with essential hypertension

(2010) Takafumi Okura et al.   Clinical and Experimental Nephrology

The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients

(2010) S. Liabeuf et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice

(2009) Qianli Yu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Death Receptors and Their Ligands in Atherosclerosis

(2008) Mary M. Kavurma et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The Death Ligand TRAIL in Diabetic Nephropathy

(2008) C. Lorz et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The pathogenesis of diabetic nephropathy

(2008) Suma Dronavalli et al.   Nature clinical practice. Endocrinology & metabolism

Expression, regulation and function of trail in atherosclerosis

(2007) Mary M. Kavurma et al.   BIOCHEMICAL PHARMACOLOGY